XML 17 R7.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Statement of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Apr. 01, 2017
Apr. 02, 2016
Operating Activities:    
Net Income Attributable to Kadant $ 8,951 $ 6,876
Net income attributable to noncontrolling interest 116 115
Net income 9,067 6,991
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 3,256 2,564
Stock-based compensation expense 1,295 1,323
Provision for losses on accounts receivable 129 76
Loss (gain) on the sale of property, plant, and equipment 41 (346)
Other items, net 180 781
Contributions to U.S. pension plan (90) (270)
Changes in current assets and liabilities, net of effects of acquisition:    
Accounts receivable (5,043) 3,259
Unbilled contract costs and fees (1,134) 4,313
Inventories (3,964) (604)
Other current assets (1,886) (1,808)
Accounts payable 805 (1,234)
Other current liabilities (973) (9,527)
Net cash provided by operating activities 1,683 5,518
Investing Activities:    
Purchases of property, plant, and equipment (1,722) (524)
Issuance of note receivable 0 (2,813)
Proceeds from sale of property, plant, and equipment 0 385
Acquisition (165) 0
Other investing activities (2) 0
Net cash used in investing activities (1,889) (2,952)
Financing Activities:    
Proceeds from issuance of debt 8,000 41,046
Repayment of debt (4,610) (125)
Tax withholding payments related to stock-based compensation (2,182) (1,980)
Dividends paid (2,078) (1,831)
Payment of debt issuance costs (654) 0
Payment of contingent consideration 0 (1,091)
Change in restricted cash 590 (58)
Other financing activities (118) 0
Net cash (used in) provided by financing activities (1,052) 35,961
Exchange Rate Effect on Cash and Cash Equivalents 1,311 460
Increase in Cash and Cash Equivalents 53 38,987
Cash and Cash Equivalents at Beginning of Period 71,487 65,530
Cash and Cash Equivalents at End of Period $ 71,540 $ 104,517